Triochem Products Ltd (TRIPR) — shareholding pattern, promoter holding, financials and share price
About Triochem Products Ltd (TRIPR)
Triochem Products Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as TRIPR and on the BSE under scrip code 512101. Its ISIN is INE331E01013.
Triochem Products engaged primarily in the business of manufacturer and exporter of pharlnaceuticals products, Apls and chemicals.
Triochem Products Ltd, founded in 1972, is a manufacturer and exporter of pharmaceuticals, APIs, and chemicals.
Despite the lack of recent investor presentations or concall transcripts, the company maintains a strong legacy in pharmaceutical manufacturing.
Listed peers in Pharmaceuticals: Vivanza Biosciences Ltd, Ganga Pharmaceuticals Ltd, Decipher Labs Ltd, Brawn Biotech Ltd, Fabino Enterprises Ltd, Shyama Computronics and Services Ltd.
Valuation & Returns
At ₹17.4 a share, Triochem Products Ltd (TRIPR) was valued at a price-to-earnings ratio of 0.05x against an industry P/E of 36.41x and a price-to-book of 0.02x on a book value of ₹842.65 per share. Solomo computes return on equity of -3.14% and return on capital employed of -2.76% from filed results.
- P/E
- 0.05x
- Industry P/E
- 36.41x
- P/B
- 0.02x
- EPS (TTM)
- ₹325.34
- Book value / share
- ₹842.65
- ROE
- -3.14%
- ROCE
- -2.76%
- ROA
- 38.22%
- Debt / equity
- 0x
- Dividend yield
- 0%
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Triochem Products Ltd (TRIPR) reported net profit of ₹7.97 crore and earnings per share of ₹325.31. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, net profit ₹8.33 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 8.82 | 0 | 0 | 0 | 0 |
| Net profit (₹ cr) | 1.32 | -0.89 | -1.01 | -0.4 | 7.97 |
| EPS (₹) | 53.88 | -36.33 | -41.22 | -16.33 | 325.31 |
| Measure | 1Y |
|---|---|
| Profit growth | 60.40% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 68.65% of Triochem Products Ltd (TRIPR) (unchanged from the previous quarter). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2002.
Largest disclosed public shareholders in Jun 2026: AMBERNATH PLASTO PACKAGING PRIVATE LIMITED 4.9%, G AMPHRAY PHARMACEUTICALS PRIVATE LIMITED 4.9%, TRIOCHEM LABORATORIES PRIVATE LIMITED 4.9%, PRAVINA NAKUM 2.94%, MITAL SHRIKANT THAKKER 2.86%, ALKA BOYED 1.49%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 68.65% | - | - | - | 31.35% |
| Mar 2026 | 68.65% | - | - | - | 31.35% |
| Dec 2025 | 68.65% | - | - | - | 31.35% |
| Sep 2025 | 68.65% | - | - | - | 31.35% |
| Jun 2025 | 68.65% | - | - | - | 31.35% |
| Mar 2025 | 68.65% | - | - | - | 31.35% |
| Dec 2024 | 68.65% | - | - | - | 31.35% |
| Sep 2024 | 68.65% | - | - | - | 31.35% |